Researcher
Catherine Verfaillie
- Disciplines:Genetics, Systems biology, Molecular and cell biology
Affiliations
- Stem Cell and Developmental Biology (Division)
Member
From1 Apr 2013 → 30 Sep 2022
Infrastructure
1 - 1 of 1
- Platform for Next Generation Screening in Quantitative Biology & Drug Discovery (Consortium coordinator)
Projects
1 - 10 of 95
- Business development of a drug screening Spin-off company based on 2D & 3D human iPSC-derived liver cell models for NASH & (i)DILI.From1 Aug 2021 → 31 Jan 2022Funding: IOF - mandates
- RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3RsFrom1 Jun 2021 → TodayFunding: H2020 - Health, demographic change and wellbeing
- Robotized Human Liver-Mimic 3D Model Platform for Efficient NAFLD and DILI Compound ScreeningFrom1 Jan 2021 → 31 Dec 2022Funding: IOF - technology validation in lab
- Advanced 3D Complex Tissues BioAssembly Platform for Precision Disease Modeling, Drug Discovery and Regenerative Medicine (3D-BioBOT)From1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- In vitro functional formation of liver sinusoidal endothelial cells in 3D culture system.From1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- iPSC-based parenchymal and sinusoidal liver cell mimics for DILI and NAFLD studies (iPSC-LiMic)From1 Oct 2020 → TodayFunding: FWO Strategic Basic Research (SBO)
- Drug discovery for Parkinson’s disease using a translational screening platformFrom1 Oct 2020 → 31 Mar 2024Funding: IOF - technology validation in lab
- OrganID: Organ-derived complex 2D/3D cultures in human diseaseFrom1 Oct 2020 → TodayFunding: FWO Strategic Basic Research (SBO)
- Proof of concept: immunotherapy in glioblastoma multiforme.From21 Sep 2020 → TodayFunding: FWO fellowships
- 3D-PADchip: Engineering 3D Perfusable human "Alzheimer's Disease (AD)-On-Chip ModelFrom28 Aug 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
331 - 340 of 375
- Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside?(2009)
Authors: Tania Roskams, Catherine Verfaillie
Pages: 594 - 603 - Adult Stem and Progenitor Cells(2009)
Authors: Martine Geraerts, Catherine Verfaillie
Pages: 1 - 21 - Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells(2009)
Authors: Marc Tjwa, Mieke Dewerchin, Lieve Moons, Catherine Verfaillie, Peter Carmeliet
Pages: 1008 - 1018 - Ox-LDL Modifies the Behavior of Bone Marrow Stem Cells and Impairs Their Endothelial Differentiation via Inhibition of Akt Activation(2009)
Authors: Ling Chu, Hong Hao, Zehao Liu, Jian Xu, Min Luo, Yu Huang, Zhenyu Chen, Catherine Verfaillie, Jay L Zweier, Zhenguo Liu
Pages: A199 - A199 - Retraction. Reyes M, Lund T, Lenvik T, Aguiar D, Koodie L, Verfaillie CM. Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001;98:2615-2625.(2009)
Authors: M Reyes, T Lund, T Lenvik, D Aguiar, L Koodie, Catherine Verfaillie
Pages: 2370 - Directed differentiation of mouse cochlear neural progenitors in vitro (Retracted article. See vol. 297, pg. C1596, 2009)(2009)
Authors: Jizhen Lin, Ling Feng, Yuki Hamajima, Masahiro Komori, Terry C Burns, Shinji Fukudome, John Anderson, Dong Wang, Catherine Verfaillie, Walter C Low
Pages: C441 - C452 - Antibiotics may impair hematopoietic recovery after cytotoxic myeloablation(2009)
Authors: Marc Tjwa, Lieve Moons, Catherine Verfaillie, Peter Carmeliet
Pages: 1608 - 1609 - Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany(2009)
Authors: Catherine Verfaillie
Pages: 245 - 255 - Immune modulatory capacities of human multipotent adult progenitor cells on T-cells on T-cell alloreactivity(2009)
Authors: Sandra Jacobs, D Zwaenepoel, V Roobrouck, J Pinxteren, W Van't Hof, R Deans, Catherine Verfaillie, S Van Gool
Pages: 837 - 837 - Greater differentiation potential of adult stem cells(2009)
Authors: Carlos Clavel-Claver, Catherine Verfaillie, U Lakshmipathy, J Chesnut, B Thyagarajan
Pages: 111 - 128
Patents
1 - 10 of 10
- Methods for differentiating cells into hepatic stellate cells (Inventor)
- Hydrogels for cell culture (Inventor)
- Nek6 inhibition to treat als and ftd (Inventor)
- Spheroidal self-assembled peptide hydrogels comprising cells (Inventor)
- Methods for differentiating cells into hepatic stellate cells (Inventor)
- Cell culture media for differentiation of stem cells into hepatocytes (Inventor)
- Methods for identifying activators and suppressors (Inventor)
- Stem cell aggregates and methods for making and using (Inventor)
- Cell therapy for myelodysplastic syndromes (Inventor)
- Optimized methods for differentiation of cells into cells with hepatocyte and hepatocyte progenitor phenotypes, cells produced by the methods, and methods for using the cells (Inventor)